Verisk Gains as Profit Beats Analysts’ Estimates: New York Mover

Verisk Analytics Inc. (VRSK), the supplier of actuarial and risk data to lenders and insurers, jumped the most since October after fourth-quarter earnings beat analysts’ estimates on increased health-care revenue.

Verisk climbed 7.7 percent to close at a record-high $58.05 in New York, the top performance in the Russell 1000 Producer Durables Index. The Jersey City, New Jersey-based firm has gained 14 percent this year, compared with the 8.7 percent advance of the 138-company index.

Net income increased 22 percent to $98.3 million in the quarter, up from $80.3 million a year earlier, Verisk said yesterday in a statement. Operating profit, which excludes some items, was 63 cents a share, beating the 54-cent average estimate of 12 analysts in a Bloomberg survey. Revenue from the firm’s health-care unit increased 89 percent to $72.8 million.

“Verisk saw high demand for its payment accuracy fraud solutions” in its health-care division, William Warmington Jr., an analyst at Raymond James & Associates Inc., wrote in a note yesterday. He rates the shares outperform.

To contact the reporter on this story: Elizabeth Bunn in New York at

To contact the editor responsible for this story: Dan Kraut at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.